Markus Raderer

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.2K citations

Oncology, Gastrointestinal Oncology, Medicine +8

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

Ventzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche et al. · Journal of Clinical Investigation · 2003 · 341 citations · Full text

New Drug, Hypertension, Heart Failure +15

Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

Alexander Becherer, Monica Szabó, Georgios Karanikas et al. · PubMed · 2004 · 206 citations

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 196 citations · Full text

Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron

Christian Müller, Susanna Pongratz, Johann Pidlich et al. · European Journal of Gastroenterology & Hepatology · 1998 · 122 citations